174 related articles for article (PubMed ID: 20213913)
21. Is photodynamic diagnosis using hypericin better than white-light cystoscopy for detecting superficial bladder carcinoma?
Sim HG; Lau WK; Olivo M; Tan PH; Cheng CW
BJU Int; 2005 Jun; 95(9):1215-8. PubMed ID: 15892804
[TBL] [Abstract][Full Text] [Related]
22. [ALA fluorescent diagnosis of bladder cancer].
Al'-Shukri SKh; Danil'chenko DI; Kënig F; Shnorr D
Urologiia; 2000; (5):48-50. PubMed ID: 11392226
[TBL] [Abstract][Full Text] [Related]
23. Comparative evaluation of the diagnostic performance of the BTA stat test, NMP22 and urinary bladder cancer antigen for primary and recurrent bladder tumors.
Giannopoulos A; Manousakas T; Gounari A; Constantinides C; Choremi-Papadopoulou H; Dimopoulos C
J Urol; 2001 Aug; 166(2):470-5. PubMed ID: 11458049
[TBL] [Abstract][Full Text] [Related]
24. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
Kumar A; Kumar R; Gupta NP
Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
[TBL] [Abstract][Full Text] [Related]
25. [Hexvix induced fluorescence blue light cystoscopy--a new perspective in superficial bladder tumors diagnosis].
Geavlete B; Mulţescu R; Georgescu D; Geavlete P
Chirurgia (Bucur); 2008; 103(5):559-64. PubMed ID: 19260632
[TBL] [Abstract][Full Text] [Related]
26. [Value of the photodynamic method in the diagnosis of superficial bladder tumors].
Lipiński MI; Jeromin LM
Wiad Lek; 2004; 57 Suppl 1():192-5. PubMed ID: 15884237
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic diagnosis of non-muscle invasive bladder cancer using hexaminolevulinic acid.
Drăgoescu O; Tomescu P; Pănuş A; Enache M; Maria C; Stoica L; Pleşea IE
Rom J Morphol Embryol; 2011; 52(1):123-7. PubMed ID: 21424043
[TBL] [Abstract][Full Text] [Related]
28. Narrow-band imaging flexible cystoscopy in the detection of clinically unconfirmed positive urine cytology.
Zhu YP; Shen YJ; Ye DW; Wang CF; Yao XD; Zhang SL; Dai B; Zhang HL; Shi GH
Urol Int; 2012; 88(1):84-7. PubMed ID: 22104957
[TBL] [Abstract][Full Text] [Related]
29. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study.
Fradet Y; Grossman HB; Gomella L; Lerner S; Cookson M; Albala D; Droller MJ;
J Urol; 2007 Jul; 178(1):68-73; discussion 73. PubMed ID: 17499291
[TBL] [Abstract][Full Text] [Related]
30. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy.
Schmidbauer J; Witjes F; Schmeller N; Donat R; Susani M; Marberger M;
J Urol; 2004 Jan; 171(1):135-8. PubMed ID: 14665861
[TBL] [Abstract][Full Text] [Related]
31. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
Raitanen MP; Leppilahti M; Tuhkanen K; Forssel T; Nylund P; Tammela T;
Ann Chir Gynaecol; 2001; 90(4):261-5. PubMed ID: 11820414
[TBL] [Abstract][Full Text] [Related]
32. Screening for bladder tumours in men aged 60-70 years with a bladder tumour marker (UBC) and dipstick-detected haematuria using both white-light and fluorescence cystoscopy.
Hedelin H; Jonsson K; Salomonsson K; Boman H
Scand J Urol Nephrol; 2006; 40(1):26-30. PubMed ID: 16452052
[TBL] [Abstract][Full Text] [Related]
33. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer.
Divrik RT; Sahin A; Altok M; Unlü N; Zorlu F
J Urol; 2007 Sep; 178(3 Pt 1):802-6; discussion 806. PubMed ID: 17632171
[TBL] [Abstract][Full Text] [Related]
34. Narrow-band imaging flexible cystoscopy in the detection of primary non-muscle invasive bladder cancer: a "second look" matters?
Shen YJ; Zhu YP; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Zhu Y
Int Urol Nephrol; 2012 Apr; 44(2):451-7. PubMed ID: 21792663
[TBL] [Abstract][Full Text] [Related]
35. [Detection of bladder cancer by narrow band imaging cystoscopy: a meta-analysis].
Xiong B; Zheng C; Zhang C; Wei W; Wang Y; Luo J; Yang H; Wang H
Zhonghua Wai Ke Za Zhi; 2014 Apr; 52(4):289-93. PubMed ID: 24924576
[TBL] [Abstract][Full Text] [Related]
36. [Fluorescent cystoscopy and transurethral electroresection in diagnosis and treatment of patients with invasive cancer of the urinary bladder].
Komiakov BK; Gorelov SI; Novikov AI; Gorelov AI; Novikov PB; Strokova LA; Al-Atar T
Urologiia; 2004; (6):37-40. PubMed ID: 15719729
[TBL] [Abstract][Full Text] [Related]
37. New cystoscopic diagnosis for interstitial cystitis/painful bladder syndrome using narrow-band imaging system.
Ueda T; Nakagawa M; Okamura M; Tanoue H; Yoshida H; Yoshimura N
Int J Urol; 2008 Dec; 15(12):1039-43. PubMed ID: 19054176
[TBL] [Abstract][Full Text] [Related]
38. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder.
Hungerhuber E; Stepp H; Kriegmair M; Stief C; Hofstetter A; Hartmann A; Knuechel R; Karl A; Tritschler S; Zaak D
Urology; 2007 Feb; 69(2):260-4. PubMed ID: 17320660
[TBL] [Abstract][Full Text] [Related]
39. Reduced bladder tumour recurrence rate associated with narrow-band imaging surveillance cystoscopy.
Herr HW; Donat SM
BJU Int; 2011 Feb; 107(3):396-8. PubMed ID: 20707789
[TBL] [Abstract][Full Text] [Related]
40. High magnification cystoscopy in the primary diagnosis of bladder tumors.
Jichlinski P; Lovisa B
Curr Opin Urol; 2011 Sep; 21(5):398-402. PubMed ID: 21730856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
